Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
3mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 4588.48
kr 153.08
kr 13777.18
Free AirMail shipping
60 tablets
kr 2446.82
kr 163.28
kr 9796.96
Free AirMail shipping
30 tablets
kr 917.49
kr 173.48
kr 5204.40
Free AirMail shipping
20 tablets
kr 407.72
kr 183.68
kr 3673.54
Free AirMail shipping
10 tablets
kr 204.06
kr 2040.63
Free AirMail shipping
7mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 1832.94
kr 183.70
kr 16532.72
Free AirMail shipping
60 tablets
kr 915.96
kr 188.80
kr 11327.82
Free AirMail shipping
30 tablets
kr 305.15
kr 193.89
kr 5816.74
Free AirMail shipping
20 tablets
kr 101.55
kr 198.99
kr 3979.71
Free AirMail shipping
10 tablets
kr 204.06
kr 2040.63
Free AirMail shipping
14mg
Package
Savings
Per tablet
Price
Order
90 tablets
kr 2292.20
kr 219.42
kr 19747.52
Free AirMail shipping
60 tablets
kr 1222.13
kr 224.52
kr 13471.01
Free AirMail shipping
30 tablets
kr 458.24
kr 229.61
kr 6888.34
Free AirMail shipping
20 tablets
kr 203.60
kr 234.71
kr 4694.11
Free AirMail shipping
10 tablets
kr 244.89
kr 2448.86
Free AirMail shipping
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.